Page last updated: 2024-09-03

omega-n-methylarginine and tak 044

omega-n-methylarginine has been researched along with tak 044 in 2 studies

Compound Research Comparison

Studies (omega-n-methylarginine)	Trials (omega-n-methylarginine)	Recent Studies (post-2010) (omega-n-methylarginine)	Studies (tak 044)	Trials (tak 044)	Recent Studies (post-2010) (tak 044)
4,411	344	336	105	8	2

Protein Interaction Comparison

Protein	Taxonomy	omega-n-methylarginine (IC50)	tak 044 (IC50)
Endothelin-1 receptor	Homo sapiens (human)		0.0002

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ghiadoni, L; Notari, M; Salvetti, A; Sudano, I; Taddei, S; Virdis, A	1
Ghiadoni, L; Magagna, A; Salvetti, A; Taddei, S; Virdis, A	1

Trials

1 trial(s) available for omega-n-methylarginine and tak 044

Article	Year
Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 2 Topics: Acetylcholine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Norepinephrine; omega-N-Methylarginine; Peptides, Cyclic; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vasoconstrictor Agents; Vasodilator Agents	2000

Article

Year

Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension.

Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 2

Topics: Acetylcholine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Norepinephrine; omega-N-Methylarginine; Peptides, Cyclic; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vasoconstrictor Agents; Vasodilator Agents

2000

Other Studies

1 other study(ies) available for omega-n-methylarginine and tak 044

Article	Year
Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension. Circulation, 1999, Oct-19, Volume: 100, Issue:16 Topics: Endothelin Receptor Antagonists; Endothelin-1; Forearm; Humans; Hypertension; Infusions, Intra-Arterial; Middle Aged; Nitric Oxide Synthase; Nitroprusside; Norepinephrine; omega-N-Methylarginine; Peptides, Cyclic; Plethysmography; Reference Values; Regional Blood Flow; Vasoconstriction; Vasodilator Agents	1999

Article

Year

Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension.

Circulation, 1999, Oct-19, Volume: 100, Issue:16

Topics: Endothelin Receptor Antagonists; Endothelin-1; Forearm; Humans; Hypertension; Infusions, Intra-Arterial; Middle Aged; Nitric Oxide Synthase; Nitroprusside; Norepinephrine; omega-N-Methylarginine; Peptides, Cyclic; Plethysmography; Reference Values; Regional Blood Flow; Vasoconstriction; Vasodilator Agents

1999